Efficacy of boric acid in comparison with lactose in treatment of cervical ectropion in cases with chronic vaginal discharge and normal colposcopic results

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017070634661N1

Enrollment

Registered

2017-07-06

Start date

2016-03-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical ectropion. Inflammatory disease of cervix uteri

Interventions

Intervention 1: 600 mg boric acid vaginal suppository once per night. Intervention 2: 600 mg lactose vaginal suppository or placebo once per night.

Treatment - Drugs

600 mg boric acid vaginal suppository once per night

600 mg lactose vaginal suppository or placebo once per night

Eligibility

Sex/Gender

Female

Age

12 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criterion was lack of treatment for ectropion in past three months. The exclusion criteria were follow-up problems, abnormal colposcopic results, acute vaginal discharge, hypersensitivity, and drug adverse effects.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Ectropion. Timepoint: before and one month after onset of the treatment. Method of measurement: colposcopy and clinical interview.	—

Secondary

Measure	Time frame
Side effects. Timepoint: one month after onset the treatment. Method of measurement: clinical examination and interview.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Soha Mirreza

Imam Hossein Hospital

sohamirreza@sbmu.ac.ir+98 21 2356 2683

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026